.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
McKesson
Medtronic
Cerilliant
Farmers Insurance
Moodys
Cipla
UBS
Express Scripts

Generated: November 17, 2017

DrugPatentWatch Database Preview

PROCARDIA Drug Profile

« Back to Dashboard

What is the patent landscape for Procardia, and when can generic versions of Procardia launch?

Procardia is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in PROCARDIA is nifedipine. There are thirty-nine drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

Pharmacology for PROCARDIA

Medical Subject Heading (MeSH) Categories for PROCARDIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-002Sep 6, 1989AB2RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-002Jul 24, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-001Sep 6, 1989AB2RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer
PROCARDIA XL
nifedipine
TABLET, EXTENDED RELEASE;ORAL019684-003Sep 6, 1989AB2RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROCARDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-002Jul 24, 1986► Subscribe► Subscribe
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-002Jul 24, 1986► Subscribe► Subscribe
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Express Scripts
QuintilesIMS
Boehringer Ingelheim
Medtronic
McKesson
AstraZeneca
Teva
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot